F13B
protein-codingcoagulation factor XIII B chain, the group of Sushi domain containing
Gene summary
This gene encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013190
Submitter: ClinGen
The relationship between F13B and Factor XIIIB deficiency inherited in the autosomal recessive pattern has been evaluated using the ClinGen Clinical Validity Framework as of July, 2020. This association was made using case-level and experimental data. Only a few pathogenic variants in this gene are reported in ClinVar, including frameshift, missense and splicing variants. F13B encodes the B subunits, which act as carrier proteins, of the coagulation factor XIII. FXIII is a transglutaminase that forms intramolecular gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules to stabilize blood clots. Factor XIIIB deficiency is characterized by a bleeding diathesis, poor wound healing and reduced Factor XIII activity and antigen levels. Mutations in F13B were first associated with this disease in humans as early as 1993 by Hashiguchi et al. (PMID: 8324218). Summary of Case Level Data (10 points): The association is seen in at least 6 probands in 5 publications (PMID: 11313256, 20331752, 8324218, 8639893, 31064749). The mechanism for disease is expected to be biallelic loss of function. A number of heterozygous individuals with Factor XIIIB deficiency have also been reported, but have not been scored in this curation (PMID: 20331752, 23913518, 26247044). Summary of Experimental Data (2.5 points): A mouse model recapitulating FXIII deficiency and rescue using rFXIIIB have been reported (PMID: 18224415). In summary, the F13B - Factor XIIIB deficiency gene-disease relationship is definitive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hemostasis/Thrombosis GCEP on July 22, 2020. (SOP Version 6).
Inheritance Pattern: AR
Disease ID:MONDO:0013190
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013190
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0018029
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013190
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic; Pharmacogenomic
Rationale: Individuals have increased bleeding and poor wound healing; awareness and management of bleeding risk in certain situations (eg, obstetric event or surgery) may decrease morbidity; Precautions should be taken related to certain agents that may provoke/worsen bleeding risk
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to F13B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001994.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 12 | 18 | |||
| missense | 1 | 1 | 105 | 7 | 114 | |
| nonsense | 3 | 3 | 6 | |||
| start loss | 0 | |||||
| frameshift | 4 | 2 | 2 | 8 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 1 | 3 | ||
| Total | 9 | 7 | 114 | 19 | 0 | 149 |
Highest pathogenic variant AF is 0.000026041505
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001985.2 | 12 | MANE Select | |
| Ensembl | ENSP00000356382.2 | 12 | MANE Select | |
| Ensembl | ENSP00000497116.1 | 5 | Standard | |
| Ensembl | ENSP00000565458.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Complement and coagulation cascades - Homo sapiens (human)
- Aminocaproic Acid Action Pathway
- Tranexamic Acid Action Pathway
- Urokinase Action Pathway
- Reteplase Action Pathway
Biological Process
- blood coagulation
- blood coagulation, fibrin clot formation
- negative regulation of cellular protein catabolic process
Cellular Component
- extracellular region
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367412
- Coding exons
- 12
- Length
- 28077
- Individuals with no LoFs
- 125641
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 78
- Defined
- 125720
- p
- 0.000314
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.568 | 312 | 342 | 0.913 | 0.0000162 | 4303 |
| Missense (PolyPhen) | 122 | 129.68 | 0.94076 | 1549 | ||
| Synonymous | 0.379 | 114 | 119 | 0.956 | 0.00000605 | 1183 |
| Loss of Function | 2.24 | 20 | 34.1 | 0.587 | 0.00000143 | 502 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00044 | 0.00043 | rare |
| Ashkenazi Jewish | 0.00011 | 0.000099 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00024 | 0.00023 | rare |
| South Asian | 0.00098 | 0.00095 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin. {ECO:0000303|PubMed:21742792, ECO:0000303|PubMed:3021194}.;
- Disease
- DISEASE: Factor XIII subunit B deficiency (FA13BD) [MIM:613235]: An autosomal recessive hematologic disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women. {ECO:0000269|PubMed:11313256, ECO:0000269|PubMed:20331752, ECO:0000269|PubMed:26247044, ECO:0000269|PubMed:8324218}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.258
Intolerance Scores
- LoFtool
- 0.508
- RVIS EVS
- 0.73
- RVIS percentile EVS
- 86.21
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.674
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |